NCT01083979
- Conditions
- Cystitis, Cystitis, Interstitial, Female Urogenital Diseases, +6 more
- Locations
-
- William Beaumont Hospital Royal Oak, Michigan, United States
Clinical trial condition
Urinary Bladder Diseases
Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.
2,289 public trials
414 recruiting studies
Urinary Bladder Diseases trial results
NCT00957424
- Conditions
- Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +78 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT01828736
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +15 more
- Locations
-
- Cliniques saint Luc - Université Catholique de Louvain Brussels, Belgium
- CHU de Besançon Besançon, France
- CHU Hôpital Saint André Bordeaux, France
- Hôpital Jean Perrin Clermont-Ferrand, France
NCT00675298
- Conditions
- Chronic Pelvic Pain Syndrome, Cystitis, Cystitis, Interstitial, +16 more
- Locations
-
- Jordan D Dimitrakoff Boston, Massachusetts, United States
Completed
Toxin Retrospective Study
NCT03042052
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- Hopital Raymond Poincare Garches, France
NCT02326168
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- The University of Texas Health Science Center San Antonio, Texas, United States
NCT01142102
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Calvary Mater Newcastle Newcastle, New South Wales, Australia
- Westmead Hospital Westmead, New South Wales, Australia
- Mater Hospital Brisbane, Queensland, Australia
NCT00321477
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Incontinence, Urinary and Urinary Bladder, Overactive, +10 more
- Locations
-
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Peoria, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site La Mesa, California, United States
Completed
High-dose ICE With Amifostine
NCT00003657
- Conditions
- AIDS-related Kaposi sarcoma, Adnexal Diseases, Bladder Cancer, +80 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT01328574
- Conditions
- Cancer of the Ureter, Carcinoma, Carcinoma, Transitional Cell, +18 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States